Octaware Technologies has accepted the resignation of Ms Rabia Khan as Non-Executive Independent Director, effective August 13, 2026. The Board of Directors formally noted the cessation during its meeting held on August 20, 2026.

Ms Khan cited pre-occupation with other professional assignments as the reason for her departure. In her resignation letter dated August 13, 2026, she confirmed there were no other material reasons for stepping down and stated that no unresolved matters required her continued involvement beyond ordinary course actions.

The company disclosed the change under Regulation 30 and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing confirms Ms Khan’s DIN is 08355059 and details the cessation date as August 13, 2026.

Board Confirmation

The Board acknowledged the resignation in compliance with Para A, Part A, Clauses 7 and 7B of Schedule III of the SEBI LODR Regulations. Ms Khan expressed appreciation to the Board, management, and employees for their support during her tenure.

Octaware Technologies has appointed Divya Mittal as an additional director in the category of non-executive independent director. The Board of Directors approved the appointment on August 17, 2026, based on the recommendation of the Nomination and Remuneration Committee.

The appointment takes effect on August 20, 2026, for a first term of five consecutive years, concluding on August 19, 2031. This tenure is subject to the approval of the company’s shareholders. Ms Mittal is not liable to retire by rotation.

Regulatory Compliance and Independence

In compliance with Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Octaware confirmed that Ms Mittal meets the criteria of independence under the Companies Act, 2013 and SEBI LODR Regulations. She has provided requisite declarations confirming she is not debarred from holding office by SEBI or any other authority and is not disqualified under Section 164 of the Companies Act, 2013.

Profile of Appointee

Divya Mittal (DIN: 11902340) holds an MBA in Marketing, a B.Sc. in Biology, and a B.Ed. She possesses more than 20 years of experience primarily within pharmaceutical and healthcare companies.

Her professional background includes:

• Current role managing HR, sales, and marketing at Dr. Fresh Assets Ltd.
• Previous tenures with Pfizer India, Cipla, and Innovex India in roles focused on sales, marketing, team management, and training.
• Training experience with Aventis Pharma and HCL Infosys.

Ms Mittal disclosed no relationships with existing directors and holds no committee memberships or chairmanships at this stage.